FDA grants approval for Abbott’s ALK Gene Test
Abbott (NYSE: ABT) announced that a new molecular diagnostic test has been approved by the U.S. Food and Drug Administration
Read moreabbott
FDA approves Abbott’s genetic test for leukemia
Earlier on Monday, Abbott Laboratories announced that a genetic test intended to diagnose chronic lymphocytic leukemia (CLL) patients has been
Read moreHospira appoints Abbott’s Dempsey to the board
Late on Wednesday, Hospira Inc. announced that William Dempsey was voted into the board of directors thus expanding the board
Read moreAbbott’s Lupron, a long-acting treatment for premature puberty, received FDA approval
On Tuesday, Abbott Laboratories announced that two longer-acting doses of Lupron, a treatment for premature puberty, have been approved by
Read more